1,1,3,3-Tetramethylguanidine
ATC code L01
Abemaciclib
Acid dissociation constant
Aclarubicin
Adagrasib
Adenosine deaminase inhibitor
Aflibercept
Alitretinoin
Alkyl sulfonate
Alkylating antineoplastic agent
Alkylation
Allantoic acid
Alpelisib
Altretamine
Alvocidib
American Society of Health-System Pharmacists
Aminolevulinic acid
Aminopterin
Amrubicin
Amsacrine
Anagrelide
Anatomical Therapeutic Chemical Classification System
Anthracycline
Anthraquinone
Antifolate
Antimetabolite
Antineoplastic
Arsenic trioxide
Asparaginase
Asparagine
Astrocytoma
Atrasentan
Axicabtagene ciloleucel
Azacitidine
Aziridine
Belinostat
Belotecan
Belzutifan
Bendamustine
Bexarotene
Biodegradable
Bisantrene
Bleomycin
Bone marrow transplant
Bortezomib
Boxed warning
Brain cancer
Brain tumour
Brexucabtagene autoleucel
Buformin
Busulfan
CAS Registry Number
Cabazitaxel
Camptotheca
Camptothecin
Capecitabine
Carboplatin
Carboquone
Carfilzomib
Carmofur
Carmustine (data page)
Celecoxib
Cell-cycle nonspecific antineoplastic agents
ChEBI
ChEMBL
ChemSpider
Chemical formula
Chemical nomenclature
Chemotherapy
Chlorambucil
Chlormethine
Ciltacabtagene autoleucel
Cisplatin
Cladribine
Clinical trial
Clofarabine
CompTox Chemicals Dashboard
Copanlisib
Cositecan
Craniotomy
Crisnatol
Crosslinking of DNA
Cyclin-dependent kinase
Cyclophosphamide
Cytarabine
Cytosine
DNA
DNA polymerase inhibitor
DNA repair
DNA replication
Dacarbazine
Dactinomycin
DailyMed
Daunorubicin
Daunorubicin/cytarabine
Decitabine
Demecolcine
Denileukin diftitox
Deoxyribonucleotide
Dicycloplatin
Dihydrofolate reductase inhibitor
Dimethylurea
Docetaxel
Doi (identifier)
Doxifluridine
Doxorubicin
DrugBank
Drug class
Drug nomenclature
Drugs.com
Duvelisib
ECHA InfoCard
Efaproxiral
Eflornithine
Elesclomol
Elsamitrucin
Emcure Pharmaceuticals
Enasidenib
Endothelin receptor antagonist
Entinostat
Enzyme inhibitor
Epacadostat
Epirubicin
Epothilone
Eribulin
Estramustine phosphate
Etirinotecan pegol
Etoglucid
Etoposide
European Community number
European Medicines Agency
Exatecan
FDA
Farnesyltransferase inhibitor
Floxuridine
Fludarabine
Fluorouracil
Food and Drug Administration
Fotemustine
Fuzuloparib
GHS hazard pictograms
GHS hazard statements
GHS precautionary statements
Gemcitabine
Gimatecan
Glasdegib
Gliadel
Glioblastoma multiforme
Glioma
Globally Harmonized System of Classification and Labelling of Chemicals
Guanine
Halogenation
Histone deacetylase inhibitor
Hodgkin's lymphoma
Hydrazine
Hydroxycarbamide
Hypomethylating agent
IMP dehydrogenase
ISBN (identifier)
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imetelstat
Inavolisib
Intercalation (biochemistry)
International Chemical Identifier
Irinotecan
Isocitrate dehydrogenase
Ivosidenib
Ixabepilone
Ixazomib
JSmol
KEGG
Larotaxel
Lethal dose
Lifileucel
Lipoxygenase inhibitor
Lisocabtagene maraleucel
List of withdrawn drugs
Lomustine
Lonidamine
Losoxantrone
Lucanthone
Lurbinectedin
Lurtotecan
Lymphoma
M phase
Mannosulfan
Masoprocol
Medical Subject Headings
Medication
MedlinePlus
Medulloblastoma
Melphalan
Melphalan flufenamide
Melting point
Menogaril
Mercaptopurine
Metformin
Methotrexate
Methyl aminolevulinate
Microtubule
Mitobronitol
Mitoguazone
Mitomycins
Mitotane
Mitotic inhibitor
Mitoxantrone
Mitozolomide
Molar mass
Multiple myeloma
Nadofaragene firadenovec
Navitoclax
Nedaplatin
Nelarabine
Nimustine
Niraparib
Niraparib/abiraterone acetate
Nitrogen mustard
Nitrosourea
Nitrosourea compounds
Non-Hodgkin lymphoma
Noxytiolin
O6-Benzylguanine
Obecabtagene autoleucel
Oblimersen
Odor
Olaparib
Olutasidenib
Omacetaxine mepesuccinate
Oprozomib
Ortataxel
Oxaliplatin
PARP inhibitor
PMID (identifier)
Paclitaxel
Padeliporfin
Palbociclib
Panobinostat
Partition coefficient
Pegaspargase
Pemetrexed
Pentostatin
Pharmaceutical drug
Phases of clinical research
Phosphodiesterase inhibitor
Phosphoinositide 3-kinase inhibitor
Photodynamic therapy
Photosensitizer
Pipobroman
Pirarubicin
Pixantrone
Platinum-based antineoplastic
Plicamycin
Plitidepsin
Podophyllum peltatum
Porfimer sodium
Porphyrin
Pralatrexate
Prednimustine
Pregnancy category
Prescription drug
Procarbazine
Proteasome inhibitor
Protein kinase inhibitor
PubChem
Purine analogue
Pyrimidine analogue
RTECS
Rabacfosadine
Raltitrexed
Ranimustine
Receptor antagonist
Regulation of therapeutic goods
Retinoid
Retinoid X receptor
Ribociclib
Ribonucleotide reductase inhibitor
Romidepsin
Rubitecan
Rucaparib
S2CID (identifier)
S phase
Satraplatin
Seliciclib
Selinexor
Semustine
Sex steroid
Silatecan
Simplified molecular-input line-entry system
Sitimagene ceradenovec
Sotorasib
Spindle poison
Standard for the Uniform Scheduling of Medicines and Poisons
Standard state
Stem cell transplantation
Streptomyces
Streptozotocin
Tabelecleucel
Tagraxofusp
Talaporfin
Talimogene laherparepvec
Taxane
Tazemetostat
Tebentafusp
Tegafur
Tegafur/gimeracil/oteracil
Temoporfin
Temozolomide
Teniposide
Tesetaxel
Testolactone
Thiopurine
Thiotepa
Thymidylate synthase inhibitor
Tiazofurin
Tiazofurine
Tigilanol tiglate
Tioguanine
Tipifarnib
Tisagenlecleucel
Topoisomerase inhibitor
Topotecan
Trabectedin
Treosulfan
Tretinoin
Triazene
Triaziquone
Triethylenemelamine
Trofosfamide
Type II topoisomerase
Type I topoisomerase
UN number
Umbralisib
Unique Ingredient Identifier
University of Texas MD Anderson Cancer Center
Uramustine
Valrubicin
Veliparib
Venetoclax
Verdinexor
Verteporfin
Vinblastine
Vinca alkaloid
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vorasidenib
Vorinostat
Vosaroxin
WHO Model List of Essential Medicines
Zorubicin